Regulatory B cells in ANCA-associated vasculitis

Annals of the Rheumatic Diseases

Volumn 72, Issue 8, 2013, Pages 1416-1419

  Wilde, B ^a,b   Thewissen, M ^a   Damoiseaux, J ^a   Knippenberg, S ^a   Hilhorst, M ^a   Van Paassen, P ^a   Witzke, O ^b   Cohen Tervaert, J W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BETA1 INTEGRIN; CD19 ANTIGEN; CD39 ANTIGEN; CD4 ANTIGEN; CORTICOSTEROID; CPG OLIGODEOXYNUCLEOTIDE; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; MEMBRANE ANTIGEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ANCA ASSOCIATED VASCULITIS; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; HUMAN; LOW DRUG DOSE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMISSION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; B CELLS; SYSTEMIC VASCULITIS; T CELLS;

ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; B-LYMPHOCYTES, REGULATORY; CELLS, CULTURED; DRUG THERAPY, COMBINATION; FLOW CYTOMETRY; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-10; LYMPHOCYTE COUNT; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 84880135117     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202986     Document Type: Article

References (20)

1. Tervaert JW, van der Woude FJ, Fauci AS, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989;149:2461-5. (Pubitemid 19283202)
2. Wilde B, van Paassen P, Witzke O, et al. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 2011;79:599-612.
3. Brouwer E, Tervaert JW, Horst G, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991;83:379-86.
4. Lamprecht P, Csernok E, Gross WL. Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis. J Intern Med 2006;260:187-91. (Pubitemid 44253632)
5. Wilde B, Thewissen M, Damoiseaux J, et al. T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther 2010;12:204.
6. Abdulahad WH, Stegeman CA, van der Geld YM, et al. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007;56:2080-91. (Pubitemid 47110408)
7. Abdulahad WH, van der Geld YM, Stegeman CA, et al. Persistent expansion of CD4 + effector memory T cells in Wegener's granulomatosis. Kidney Int 2006;70:938-47. (Pubitemid 44285972)
8. Wilde B, Dolff S, Cai X, et al. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrol Dial Transplant 2009;24:161-71.
9. Wilde B, Hua F, Dolff S, et al. Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis. Rheumatology (Oxford) 2012;51:1188-97.
10. Kalampokis I, Yoshizaki A, Tedder T. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res Ther 2013;15:S1.
11. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012;30:221-41.
12. Watanabe R, Ishiura N, Nakashima H, et al. Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity. J Immunol 2010;184:4801-09.
13. Wolf SD, Dittel BN, Hardardottir F, et al. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996;184:2271-8. (Pubitemid 27023727)
14. Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011;117:530-41.
15. Blair PA, Norena LY, Flores-Borja F, et al. CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients. Immunity 2010;32:129-40.
16. Knippenberg S, Peelen E, Smolders J, et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J. Neuroimmunol. 2011;239:80-6.
17. Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013;65: 1-11.
18. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's Granulomatosis. Arthritis Rheum 1990;33:1101-07. (Pubitemid 20273294)
19. Fletcher JM, Lonergan R, Costelloe L, et al. CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis. J Immunol 2009;183:7602-10.
20. Lampropoulou V, Hoehlig K, Roch T, et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008;180:4763-73.